XXXX receptors in @entity1 brain and spinal cord tumors.

@entity1 @entity172 @entity808 @entity440 @entity1420 @entity1313 @entity5 @entity189 @entity18871 @entity11 @entity134 @entity1653 @entity342 @entity976
Previous investigators have shown evidence of hormonal receptor protein in @entity1 @entity1313 . In spite of conflicting results, antiestrogen agents (e.g., @entity440 ) have been used in clinical trials of recurrent unresectable @entity1653 . In an effort to accrue further comprehensive in vitro data on this subject, we have evaluated 50 @entity1 brain and @entity5 for @entity172 , @entity1420 , and @entity342 receptor markers. Twenty-nine of the 50 @entity5 were @entity1653 . The other 21 included 11 @entity11 of various grades, 5 @entity808 , 3 metastatic @entity189 , 1 @entity18871 , and 1 @entity976 . Only 8 @entity5 , all @entity1653 , were positive for both @entity1420 and @entity342 receptors. The 8th @entity5 was positive for all three receptor proteins. Our study did not find a significant relationship between @entity1653 and the presence of @entity134 receptor protein. We conclude that the use of antiestrogen agents is not indicated in the treatment of @entity1653 . No significant relationship to sex, menopausal status, @entity5 type, or @entity5 location was observed.
